Synthesizing molecules with highly specific targets could be a promising avenue for cancer treatment and become a research focus, Such as HLA-A*2402-restricted KIF20A-derived peptide vaccine (31), NEO-PV-01 (32), UV1 (33). The gene discussed is KIF20A; the disease is cancer.